Related Experiment Video
Updated: May 5, 2026
08:40
Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy
Published on: August 1, 2013
17.7K
Tumoricidal activity of human dendritic cells
Jurjen Tel1, Sébastien Anguille2, Claire E J Waterborg1
1Department of Tumor Immunology, Nijmegen Centre for Molecular Life Sciences, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.
Trends in Immunology
|November 23, 2013
Summary
Dendritic cells (DCs), typically known as antigen-presenting cells, can also directly kill cancer cells. This review explores the cytotoxic potential of these "killer DCs" for future cancer immunotherapy strategies.
Area of Science:
- Immunology
- Cell Biology
- Cancer Research
Background:
- Dendritic cells (DCs) are professional antigen-presenting cells (APCs) crucial for initiating immune responses against pathogens and tumors.
- The DC family comprises heterogeneous subsets, primarily myeloid DCs (mDCs) and plasmacytoid DCs (pDCs), with distinct characteristics.
- Recent findings suggest DCs possess direct cytotoxic capabilities, particularly against cancer cells.
Purpose of the Study:
- To review the understudied cytotoxic function of human dendritic cells.
- To explore the potential of dendritic cells as direct effector cells in cancer immunity.
- To discuss the implications of
Main Methods:
- Literature review of existing studies on dendritic cell subsets and their functions.
- Analysis of evidence supporting the direct cytotoxic activity of myeloid and plasmacytoid DCs.
- Synthesis of findings regarding the role of DCs in cancer cell killing.
Main Results:
- Dendritic cells, including myeloid and plasmacytoid subsets, exhibit direct cytotoxic effector functions.
- This cytotoxic activity is specifically observed against various cancer cells.
- Evidence supports a dual role for DCs: antigen presentation and direct tumor cell killing.
Conclusions:
- Human dendritic cells possess a previously underappreciated cytotoxic capacity against cancer cells.
- These
Related Concept Videos
01:27Cytotoxic T Cells-mediated Immune Response
7.1K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
7.1K
01:27Tumor Immunotherapy
2.6K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.6K